Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Development Agreement with Vertoro

21 Sep 2022 07:00

RNS Number : 0650A
Quadrise Fuels International PLC
21 September 2022
 

21 September 2022

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

Joint Development Agreement with Vertoro

Quadrise (AIM:QFI), the supplier of MSAR® and bioMSAR™ emulsion technology and fuels is pleased to announce the entry of a Joint Development Agreement ("JDA") with lignin biofuel specialists, Vertoro BV ("Vertoro").

 

Vertoro is the supplier of sustainable biomass-based biofuels extracted from abundant agricultural and forestry residues using their proprietary Goldilocks® technology. GEM® is a crude lignin oil that's a potential alternative to methanol and is being developed in conjunction with Maersk and CSO™ is an advanced crude sugar oil that's a water soluble by-product of the Goldilocks® process. The total market for these lignin residues today is estimated to be around 200 billion tonnes per annum.

 

Under the JDA, the Company and Vertoro will collaborate in seeking to progress the use of Vertoro's CSO™ as a potential cost-effective supplement or alternative to glycerine in Quadrise's bioMSAR™ fuel. The JDA may also present opportunities for the Company to supply MSAR® blending technology at Vertoro's CSO™ plants or biorefineries under future agreements with Vertoro or Vertoro's partners.

 

Quadrise has successfully produced stable blends of CSO™ based bioMSAR™ emulsions at laboratory scale at the Quadrise Research Facility, with diesel engine tests now being jointly planned during the next 12 months. These tests will scale up and accelerate the potential supply of low cost CSO™ bioMSAR™ for the marine sector. The parties have filed a joint patent for CSO™ based bioMSAR™. 

Further announcements in relation to progress under the JDA will be made, as appropriate, in due course.

Commenting on this agreement Jason Miles, CEO of QFI, said:

"Quadrise is delighted to have signed this JDA with Vertoro, having worked with their team for over a year. Lignin-based fuels are potentially the most price competitive net-zero biofuel solutions and this joint collaboration fits well with our plans to commercialise bioMSAR™ with MSC Shipmanagement and others, as well as advancing our programme to supply net-zero bioMSAR™ by 2030. Vertoro's CSO™ combined with Quadrise's bioMSAR™ technology offers a compelling solution for the marine sector to accelerate decarbonisation and emissions reduction efforts economically and safely."

Commenting on this agreement Michael Boot, Co-founder and CEO of Vertoro, said:

"Sugar has been Mother Nature's fuel of choice for over 3 billion years. Today, we announce a unique pathway to use our crude sugar oil, produced from sustainable forestry and agricultural 2G biomass residues, as a drop-in for heavy fuel oil-based biofuels through this new partnership with Quadrise."

For further information please contact:

 

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Broker

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs

Fiona Conroy

Public & Investor Relations

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, providing innovative lower cost and lower carbon alternatives to fuel oil and biofuels in the global power generation, shipping, industrial and refining industries.

 

Learn more: www.quadrisefuels.com

 

Certain of the information contained within this announcement is deemed by the Company to constitute inside information as stipulated under The Market Abuse Regulation (EU 596/2014) pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2018. Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
JVELMMBTMTTTTMT
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSRoyalty Agreement
24th Feb 20147:00 amRNSUpdate on active programmes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.